| 000 | 01727 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513122752.0 | ||
| 264 | 0 | _c19970825 | |
| 008 | 199708s 0 0 eng d | ||
| 022 | _a0360-3016 | ||
| 024 | 7 |
_a10.1016/s0360-3016(97)00010-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYao, M S | |
| 245 | 0 | 0 |
_aThe effect of M-stage on patterns of failure in posterior fossa primitive neuroectodermal tumors treated on CCG-921: a phase III study in a high-risk patient population. _h[electronic resource] |
| 260 |
_bInternational journal of radiation oncology, biology, physics _cJun 1997 |
||
| 300 |
_a469-76 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aCranial Fossa, Posterior |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNeuroectodermal Tumors, Primitive _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Failure |
| 700 | 1 | _aMehta, M P | |
| 700 | 1 | _aBoyett, J M | |
| 700 | 1 | _aLi, H | |
| 700 | 1 | _aDonahue, B | |
| 700 | 1 | _aRorke, L B | |
| 700 | 1 | _aZeltzer, P M | |
| 773 | 0 |
_tInternational journal of radiation oncology, biology, physics _gvol. 38 _gno. 3 _gp. 469-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0360-3016(97)00010-2 _zAvailable from publisher's website |
| 999 |
_c9211860 _d9211860 |
||